Neoadjuvant Long-course Chemoradiation Plus PD-1 Blockade for Mid-low Locally Advanced Rectal Cancer — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(8 sites)
China
Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing Municipality Beijing Cancer Hospital, Beijing, Beijing Municipality Beijing Chaoyang Hospital, Capital Medical University, Beijing, Beijing Municipality Beijing Hospital, Beijing, Beijing Municipality Peking Union Medical College Hospital, Beijing, Beijing Municipality Peking University First Hospital, Beijing, Beijing Municipality Peking University People's Hospital, Beijing, Beijing Municipality Xuanwu Hospital, Capital Medical University, Beijing, Beijing Municipality Age range
18 Years – 75 Years
Last updated January 2024